Abstract
Background
The Charlson Comorbidity Index (CCI) originally was developed to predict mortality within 1 year of hospital admission in patients without trauma. As it includes factors associated with medical and surgical complexities, it also may be useful as a predictive tool for hospital readmission after orthopaedic surgery, but to our knowledge, this has not been studied.
Questions/purposes
We asked whether an increased score on the CCI was associated with (1) readmission, (2) an increased risk of surgical site infection or other adverse events, (3) transfusion risk, or (4) mortality after orthopaedic surgery.
Methods
A total of 30,129 orthopaedic surgeries performed between 2008 and 2011 without any orthopaedic surgery in the preceding 30 days were analyzed. International Classification of Diseases, 9th Revision codes were used to identify diagnoses, procedures, surgery-related adverse events, surgical site infection, and comorbidities as listed in the updated and reweighted CCI. A total of 913 patients (3.0%) were readmitted within 30 days after discharge; in 393 (1.4%) patients adverse events occurred; 417 patients (1.4%) had a surgical site infection develop; 211 (0.7%) needed transfusions, and 56 (0.2%) died within 30 days after surgery. Ordinary least squares regression analyses were used to determine whether the CCI was associated with these outcomes.
Results
The CCI accounted for 10% of the variation in readmissions. Every point increase in CCI score added an additional 0.45% risk in readmission for patients undergoing arthroplasty, 0.63% for patients undergoing trauma surgery, and 0.9% risk for patients undergoing spine surgery (all p < 0.01). The CCI was not associated with surgical site infection or other adverse events, but accounted for 8% of the variation in transfusion rate and 10% of the variation in mortality within 30 days of surgery.
Conclusions
The CCI can be used to estimate the risk of readmission after arthroplasty, hand and upper extremity surgery, spine surgery, and trauma surgery. It also can be used to estimate the risk of transfusion after arthroplasty, spine, trauma, and oncologic orthopaedic surgery and the risk of mortality after shoulder, trauma, and oncologic orthopaedic surgery.
Level of Evidence
Level IV, prognostic study. See the Instructions for Authors for a complete description of levels of evidence
Similar content being viewed by others
References
Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P. Estimating the transfusion risk following total knee arthroplasty. Orthopedics. 2012;35:e1465–1471.
Arrigo RT, Kalanithi P, Cheng I, Alamin T, Carragee EJ, Mindea SA, Boakye M, Park J. Charlson score is a robust predictor of 30-day complications following spinal metastasis surgery. Spine (Phila Pa 1976). 2011;36:E1274–1280.
Ashton CM, Kuykendall DH, Johnson ML, Wray NP, Wu L. The association between the quality of inpatient care and early readmission. Ann Intern Med. 1995;122:415–421.
Aynardi M, Jacovides CL, Huang R, Mortazavi SM, Parvizi J. Risk factors for early mortality following modern total hip arthroplasty. J Arthroplasty. 2013;28:517–520.
Benbassat J, Taragin M. Hospital readmissions as a measure of quality of health care: advantages and limitations. Arch Intern Med. 2000;160:1074–1081.
Burke RE, Coleman EA. Interventions to decrease hospital readmissions: keys for cost-effectiveness. JAMA Intern Med. 2013;173:695–698.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
Folk JW, Starr AJ, Early JS. Early wound complications of operative treatment of calcaneus fractures: analysis of 190 fractures. J Orthop Trauma. 1999;13:369–372.
Gabbe BJ, Magtengaard K, Hannaford AP, Cameron PA. Is the Charlson Comorbidity Index useful for predicting trauma outcomes? Acad Emerg Med. 2005;12:318–321.
Hardy JC, Hung M, Snow BJ, Martin CL, Tashjian RZ, Burks RT, Greis PE. Blood transfusion associated with shoulder arthroplasty. J Shoulder Elbow Surg. 2013; 22:233–239
Hendren S, Morris AM, Zhang W, Dimick J. Early discharge and hospital readmission after colectomy for cancer. Dis Colon Rectum. 2011;54:1362–1367.
Higuera CA, Elsharkawy K, Klika AK, Brocone M, Barsoum WK. 2010 Mid-America Orthopaedic Association Physician in Training Award: predictors of early adverse outcomes after knee and hip arthroplasty in geriatric patients. Clin Orthop Relat Res. 2011;469:1391–1400.
Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418–2148.
Jordan CJ, Goldstein RY, Michels RF, Hutzler L, Slover JD, Bosco JA 3rd. Comprehensive program reduces hospital readmission rates after total joint arthroplasty. Am J Orthop (Belle Mead NJ). 2012;41:E147–151.
Kadar A, Chechik O, Steinberg E, Reider E, Sternheim A. Predicting the need for blood transfusion in patients with hip fractures. Int Orthop. 2013;37:693–700.
Kocher RP, Adashi EY. Hospital readmissions and the Affordable Care Act: paying for coordinated quality care. JAMA. 2011;306:1794–1795.
Kurtz SM, Lau E, Ong KL, Carreon L, Watson H, Albert T, Glassman S. Infection risk for primary and revision instrumented lumbar spine fusion in the Medicare population. J Neurosurg Spine. 2012;17:342–347.
Mantilla CB, Wass CT, Goodrich KA, Johanns CJ, Kool ML, Zhu X, Corredor JA, Warner DO, Joyner MJ, Berry DJ, Schroeder DR, Sprung J. Risk for perioperative myocardial infarction and mortality in patients undergoing hip or knee arthroplasty: the role of anemia. Transfusion. 2011;51:82–91.
McCarthy D, Johnson MB, Audet AM. Recasting readmissions by placing the hospital role in community context. JAMA. 2013;309:351–352.
Memtsoudis SG, Ma Y, Chiu YL, Walz JM, Voswinckel R, Mazumdar M. Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement. Anesth Analg. 2010;111:1110–1116.
Memtsoudis SG, Pumberger M, Ma Y, Chiu YL, Fritsch G, Gerner P, Poultsides L, Valle AG. Epidemiology and risk factors for perioperative mortality after total hip and knee arthroplasty. J Orthop Res. 2012;30:1811–1821.
Miller AG, Margules A, Raikin SM. Risk factors for wound complications after ankle fracture surgery. J. Bone Joint Surg Am. 2012;94:2047–2052.
Moore L, Thomas Stelfox H, Turgeon AF, Nathens AB, Sage NL, Emond M, Bourgeois G, Lapointe J, Gagné M. Rates, patterns, and determinants of unplanned readmission after traumatic injury: a multicentre cohort study. Ann Surg. 2013 Mar 8. [Epub ahead of print]
Navaneethan U, Gutierrez NG, Jegadeesan R, Venkatesh PG, Butt M, Sanaka MR, Vargo JJ, Parsi MA. Delay in performing ERCP and adverse events increase the 30-day readmission risk in patients with acute cholangitis. Gastrointest Endosc. 2013;78:81–90.
Neuhaus V, King J, Hageman MG, Ring DC. Charlson comorbidity indices and in-hospital deaths in patients with hip fractures. Clin Orthop Relat Res. 2013;471:1712–1719.
Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–682.
Sanders RD, Bottle A, Jameson SS, Mozid A, Aylin P, Edger L, Ma D, Reed MR, Walters M, Lees KR, Maze M. Independent preoperative predictors of outcomes in orthopedic and vascular surgery: the influence of time interval between an acute coronary syndrome or stroke and the operation. Ann Surg. 2012;255:901–907.
Schneider EB, Hyder O, Brooke BS, Efron J, Cameron JL, Edil BH, Schulick RD, Choti MA, Wolfgang CL, Pawlik TM. Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. J Am Coll Surg. 2012;214:390–398; discussion 398–399.
Schumer RA, Chae JS, Markert RJ, Sprott D, Crosby LA. Predicting transfusion in shoulder arthroplasty. J Shoulder Elbow Surg. 2010;19:91–96.
Shu CC, Lin YF, Hsu NC, Ko WJ. Risk factors for 30-day readmission in general medical patients admitted from the emergency department: a single centre study. Intern Med J. 2012;42:677–682.
Singh JA, Jensen MR, Harmsen WS, Gabriel SE, Lewallen DG. Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty. Ann Rheum Dis. 2011;70:2082–2088.
SooHoo NF, Eagan M, Krenek L, Zingmond DS. Incidence and factors predicting pulmonary embolism and deep venous thrombosis following surgical treatment of ankle fractures. Foot Ankle Surg. 2011;17:259–262.
Soohoo NF, Farng E, Lieberman JR, Chambers L, Zingmond DS. Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop Relat Res. 2010;468:2363–2371.
SooHoo NF, Lieberman JR, Ko CY, Zingmond DS. Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am. 2006;88:480–485.
Teixeira A, Trinquart L, Raphael M, Bastianic T, Chatellier G, Holstein J. Outcomes in older patients after surgical treatment for hip fracture: a new approach to characterise the link between readmissions and the surgical stay. Age Ageing. 2009;38:584–589.
Viens NA, Hug KT, Marchant MH, Cook C, Vail TP, Bolognesi MP. Role of diabetes type in perioperative outcomes after hip and knee arthroplasty in the United States. J Surg Orthop Adv. 2012;21:253–260.
Zekry D, Loures Valle BH, Graf C, Michel JP, Gold G, Krause KH, Herrmann FR. Prospective comparison of 6 comorbidity indices as predictors of 1-year post-hospital discharge institutionalization, readmission, and mortality in elderly individuals. J Am Med Dir Assoc. 2012;13:272–278.
Author information
Authors and Affiliations
Corresponding author
Additional information
Each author certifies that he or she, or a member of his or her immediate family, has no funding or commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.
All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research editors and board members are on file with the publication and can be viewed on request.
Each author certifies that his or her institution approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.
Appendices
Appendix 1. ICD-9 codes for variables used in this study*
Diagnosis | Corresponding ICD-9 codes |
---|---|
Surgical site infection | |
Other specified local infections of skin and subcutaneous tissue | 686.8 |
Unspecified local infection of skin and subcutaneous tissue | 686.9 |
Unspecified infection of bone, site unspecified | 730.90 |
Unspecified infection of bone, shoulder region | 730.91 |
Unspecified infection of bone, upper arm | 730.92 |
Unspecified infection of bone, forearm | 730.93 |
Unspecified infection of bone, hand | 730.94 |
Unspecified infection of bone, pelvic region and thigh | 730.95 |
Unspecified infection of bone, lower leg | 730.96 |
Unspecified infection of bone, ankle and foot | 730.97 |
Unspecified infection of bone, other specified sites | 730.98 |
Unspecified infection of bone, multiple sites | 730.99 |
Infection and inflammatory reaction due to unspecified device, implant, and graft | 996.60 |
Infection and inflammatory reaction due to internal joint prosthesis | 996.66 |
Infection and inflammatory reaction due to other internal orthopedic device, implant, and graft | 996.67 |
Infection and inflammatory reaction due to other internal prosthetic device, implant, and graft | 996.69 |
Infected postoperative seroma | 998.51 |
Other postoperative infection | 998.59 |
Posttraumatic wound infection not elsewhere classified | 958.3 |
Surgical adverse event | |
Unspecified mechanical complication of internal orthopedic device, implant, and graft | 996.40 |
Other mechanical complication of prosthetic joint implant | 996.47 |
Other mechanical complication of other internal orthopedic device, implant, and graft | 996.49 |
Other complications due to internal joint prosthesis | 996.77 |
Other complications due to other internal orthopedic device, implant, and graft | 996.78 |
Other complications due to other internal prosthetic device, implant, and graft | 996.79 |
Complications of unspecified reattached extremity | 996.90 |
Complications of reattached hand | 996.92 |
Complications of reattached finger(s) | 996.93 |
Complications of reattached upper extremity, other and unspecified | 996.94 |
Complication of reattached foot and toe(s) | 996.95 |
Complication of other specified reattached body part | 996.99 |
Unspecified complication of amputation stump | 997.60 |
Other amputation stump complication | 997.69 |
Surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation | E878.1 |
Amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation | E878.5 |
Other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation | E878.8 |
Unspecified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation | E878.9 |
Appendix 2. Comorbidities as listed in the updated CCI with corresponding ICD 9 codes as used in this study*
Diagnosis | Corresponding ICD9 codes |
---|---|
Congestive heart failure | 398.91, 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 425.4–425.9, 428.x |
Dementia | 290.x, 294.1, 331.2 |
Chronic pulmonary disease | 416.8, 416.9, 490.x–505.x, 506.4, 508.1, 508.8 |
Rheumatologic disease | 446.5, 710.0–710.4, 714.0–714.2, 714.8, 725.x |
Mild liver disease | 070.22, 070.23, 070.32, 070.33, 070.44, 070.54, 070.6, 070.9, 570.x, 571.x, 573.3, 573.4, 573.8, 573.9, V42.7 |
Diabetes with chronic complications | 250.4–250.7 |
Hemiplegia or paraplegia | 334.1, 342.x, 343.x, 344.0, 344.6, 344.9 |
Renal disease | 403.01, 403.11, 403.91, 404.02, 404.03, 404.12, 404.13, 404.92, 404.93, 582.x, 583.0–583.7, 585.x, 586.x, 588.0, V42.0, V45.1, V56x |
Any malignancy, including leukemia and lymphoma | 140.x–172.x, 174.x–195.8, 200.x–208.x, 238.6 |
Moderate or severe liver disease | 456.0–456.2, 572.2–572.8 |
Metastatic solid tumor | 196.x–199.x |
HIV/AIDS | 042.x–044.x |
About this article
Cite this article
Voskuijl, T., Hageman, M. & Ring, D. Higher Charlson Comorbidity Index Scores are Associated With Readmission After Orthopaedic Surgery. Clin Orthop Relat Res 472, 1638–1644 (2014). https://doi.org/10.1007/s11999-013-3394-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-013-3394-8